Logo

American Heart Association

  15
  0


Final ID:

Discussant: SUMMIT CMR

  • Kramer, Chris  ( CCHMC , Cincinnati , Ohio , United States )
  • Rider, Oliver  ( CCHMC , Cincinnati , Ohio , United States )
  • Wilcox, Jane  ( NORTHWESTERN UNIVERSITY , Chicago , Illinois , United States )
  • Author Disclosures:
    Chris Kramer: No Answer | Oliver Rider: DO NOT have relevant financial relationships | Jane Wilcox: DO have relevant financial relationships ; Advisor:Abiomed:Active (exists now) ; Consultant:Astra Zeneca:Past (completed) ; Speaker:Boehringer Ingelheim:Active (exists now) ; Consultant:Abbott:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Featured Science: Incretin Modulation: Is a New Standard of Care Emerging?

Monday, 11/18/2024 , 01:30PM - 02:45PM

Featured Science

More abstracts on this topic:
Benefits of Semaglutide on Chronic Kidney Disease Outcomes by Cardiovascular Status or Risk in the FLOW trial

Tuttle Katherine, Mann Johannes, Perkovic Vlado, Pratley Richard, Ridker Paul, Rossing Peter, Schmieder Roland, Shamkhalova Minara S., Sreenivasamurthy L, Mahaffey Kenneth, Bakris George, Bang Casper, Bax Willem, Belmar Nicolas, Brown Paul, Cherney David, Chernin Gil, Lim Soo Kun

Discussant: SUMMIT

Lewis Eldrin

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available